Company profile
GSRX Industries Inc.
OTC: GSRX · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Dorado, PRCIK 0001381240Reports USD
#618 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 4GM —SS 33
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ filing timeliness, return on equity
Methodology →Revenue TTM
$10.1M
Rev growth YoY (TTM)
-5.5%
Net income (FY)
-$36.3M
Employees
4
as of 2026-08-30
Market cap
$8.2k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$11.0M$11.0M2019
Net income-$36.3M-$36.3M2019
Operating income-$25.4M-$25.4M2019
Total assets$8.0M$8.0M2019
Liabilities$3.6M$3.6M2019
Equity$4.6M$4.6M2019
Revenue by segment
Filed disclosures · FY2019
By product
Retail100%
Wholesale0%
By geography
Puerto Rico94%
California5%
Texas1%
Tennessee0%
The read
What is GSRX Industries Inc.’s revenue?
GSRX Industries Inc. booked $11.0M in FY2019 revenue, growing 310% year over year — faster than 92% of Healthcare companies we track, at a -329.5% net margin.
Peers · Healthcare
NEXGEL, Inc.51DCaribou Biosciences, Inc.43DBellRock Brands Inc.——Veri Medtech Holdings Inc.46DOntrak, Inc.——Crescent Biopharma, Inc.65BKey facts
CEOTroy Nihart
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersDorado, PR
ExchangeOTC: GSRX
Employees4
IPO date2007-12-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.